FDA PMA FDA Class 3 Approved 🇺🇸 United States

Excimer Laser System

PMA: P930016 · Supplement: S031 · Decision Dec 1, 2008
Classifications
1
FEI Numbers
9
Registration Numbers
10

Basic Information

Device Name
Excimer Laser System
Trade Name
VISX STAR S4 IR EXCIMER LASER SYSTEM
PMA Number
P930016
Supplement Number
S031
Device Class
FDA Class 3
Product Code
LZS
Generic Name
Excimer laser system
Medical Specialty
Unknown
Advisory Committee
Ophthalmic
Decision
Approved
Decision Code
APPR
Decision Date
December 1, 2008
Date Received
August 11, 2008
Supplement Type
Normal 180 Day Track
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR MODIFICATION OF THE STARPATIENT'S CHAIR. THE DEVICE, AS MODIFIED, WILL HE MARKETED UNDER THE TRADE NAME STAR S4IR EXCIMER LASER SYSTEM AND IS INDICATED FOR WAVE FRONT-GUIDED (WFG) LASER ASSISTED INSITU KERATOMILEUSIS (LAS1K) TO ACHIEVE MONOVISION BY THE TARGETED RETENTION OF MYOPIA(-1.25 TO -2.00 D) IN THE NON-DOMINANT EYE OF PRESBYOPIC MYOPES:1) 40 YEARS OR OLDER WHO MAY BENEFIT FROM INCREASED SPECTACLE INDEPENDENCE ACROSS A RANGE OF DISTANCES WITH USEFUL NEAR VISION;2) WITH MYOPIC ASTIGMATISM UP TO -6.00 D MRSE. WITH CYLINDER UP TO -3.00 D, ANDMINIMUM PRE-OPERATIVE MYOPIA IN THEIR NON-DOMINANT EYE AT LEAST AS GREAT AS THEIRTARGETED MYOPIA;3) WITH DOCUMENTED EVIDENCE OF A CHANGE IN MANIFEST REFRACTION OF NO MORE THAN 0.50 D(IN BOTH CYLINDER AND SPHERE COMPONENTS) FOR AT LEAST ONE YEAR PRIOR TO THE DATE OFPREOPERATIVE EXAMINATION; AND4) WITH A SUCCESSFUL PREOPERATIVE TRIAL OF MONOVISION OR HISTORY OF MONOVISIONEXPERIENCE.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LZS Excimer Laser System